Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

OBJECTIVES: The aim of the study was to evaluate the cost-effectiveness (CE) of treatment with eplerenone versus standard care in adult patients with New York Heart Association class II chronic heart failure and reduced left ventricular ejection fraction from the perspective of the Greek national he...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clinicoecon Outcomes Res
Päätekijät: Athanasakis, Kostas, Bilitou, Aikaterini, Lee, Dawn, Karampli, Eleftheria, Karavidas, Apostolos, Parissis, John, Sykara, Georgia, Kyriopoulos, John
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2016
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5066703/
https://ncbi.nlm.nih.gov/pubmed/27785081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S107831
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia